Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 2
2014 2
2015 1
2018 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Exogenous reinfection of tuberculosis in a low-burden area.
Schiroli C, Carugati M, Zanini F, Bandera A, Di Nardo Stuppino S, Monge E, Morosi M, Gori A, Matteelli A, Codecasa L, Franzetti F. Schiroli C, et al. Among authors: di nardo stuppino s. Infection. 2015 Dec;43(6):647-53. doi: 10.1007/s15010-015-0759-9. Epub 2015 Mar 10. Infection. 2015. PMID: 25754899
Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial.
Fabbiani M, Gagliardini R, Ciccarelli N, Quiros Roldan E, Latini A, d'Ettorre G, Antinori A, Castagna A, Orofino G, Francisci D, Chinello P, Madeddu G, Grima P, Rusconi S, Del Pin B, Lombardi F, D'Avino A, Focà E, Colafigli M, Cauda R, Di Giambenedetto S, De Luca A; ATLAS-M Study Group. Fabbiani M, et al. J Antimicrob Chemother. 2018 Jul 1;73(7):1955-1964. doi: 10.1093/jac/dky123. J Antimicrob Chemother. 2018. PMID: 29668978 Clinical Trial.
Maraviroc as intensification strategy in HIV-1 positive patients with deficient immunological response: an Italian randomized clinical trial.
Rusconi S, Vitiello P, Adorni F, Colella E, Focà E, Capetti A, Meraviglia P, Abeli C, Bonora S, D'Annunzio M, Di Biagio A, Di Pietro M, Butini L, Orofino G, Colafigli M, d'Ettorre G, Francisci D, Parruti G, Soria A, Buonomini AR, Tommasi C, Mosti S, Bai F, Di Nardo Stuppino S, Morosi M, Montano M, Tau P, Merlini E, Marchetti G. Rusconi S, et al. Among authors: di nardo stuppino s. PLoS One. 2013 Nov 14;8(11):e80157. doi: 10.1371/journal.pone.0080157. eCollection 2013. PLoS One. 2013. PMID: 24244635 Free PMC article. Clinical Trial.
Treatment outcome in HIV+ patients receiving 3- or 4-drug regimens during PHI.
Bottani GM, Oreni ML, Orofino G, Tau P, Di Nardo Stuppino S, Colella E, Carosella S, Guastavigna M, Ghisetti V, Micheli V, Galli M, Rusconi S. Bottani GM, et al. Among authors: di nardo stuppino s. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19778. doi: 10.7448/IAS.17.4.19778. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25397522 Free PMC article.